Target intelligence / Profile preview

Vaccinia Virus Antigen

Molecular classification: Viral Protein, Antigen

Overview

Vaccinia virus antigens are proteins or protein fragments derived from the vaccinia virus. These antigens are recognized by the immune system and play a central role in both natural immunity to infection and vaccine-induced protection against smallpox and related viruses. Key antigenic proteins include A17, A27, A28, D8, H3, L1 (MV); A33 & B5 (EV). These antigens elicit both humoral and cellular immune responses and are used in vaccines and research tools.

Biological functions

Immune responseViral entryViral assemblyViral spread

Disease associations

Infection

Beyond the preview

Go deeper on Vaccinia Virus Antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaccinia Virus Antigen.

Explore the full profile